androstanolone
← Previous: androstanedione | 🏠 All Substances | 📊 Complete Table | Next: androstatrienedione →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | July 15, 2024 |
| GUID | a7aaedb7-af9a-46eb-9e37-ce1f46a7cb32 |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 08J2K08A3Y · CAS: 521-18-6
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H30O2 |
| Molecular Weight | 290.4 g/mol |
| IUPAC Name | (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one |
| InChIKey | NVKAWKQGWWIWPM-ABEVXSGRSA-N |
📊 Complete Table | 🏠 All Substances
Substance 191 of 880